Evvy, the leading at-home vaginal microbiome testing and care company is closing the gender health gap by leveraging overlooked female biomarkers, starting with the vaginal microbiome.
Amboy Street is excited to support Evvy alongside notable co-investors LabCorp and General Catalyst. LabCorp, which operates the largest clinical laboratory network in the world, is investing in Evvy to partner in the evolution of their data platform and solutions.
Vaginal discomfort is one of the top reasons women seek healthcare advice, and over 90% of these cases can be attributed to imbalances in the vaginal microbiome. The latest research shows groundbreaking links between the vaginal microbiome and critical female health outcomes like infertility, STIs, preterm birth, gynecologic cancers, and more. Yet the vaginal microbiome remains under-researched, and current standards for vaginal health testing and treatment are underpinned by overly simplistic methods like microscopy and brute-force antibiotics.
In 2021, Evvy launched their Vaginal Health Test, the first at-home vaginal microbiome test to use metagenomic sequencing to tell you what’s up down there, why it matters, and what you can do about it. Now, Evvy’s larger platform is the first vaginal healthcare service to bring together state-of-the-art testing, precision clinical care, and 1:1 coaching to give women and people with vaginas the care they deserve.
With the funding, Evvy will be scaling their testing and care platform while building their new data discovery engine — starting with vaginal infections, then expanding to tackle an even broader range of health issues, including the vaginal microbiome’s role in IVF failure and preterm birth.
Priyanka Jain, Founder of Evvy, has also partnered with New York City Mayor, Eric Adams to create a model of improved Women’s Health in New York City and beyond. As she said, “we finally have the opportunity to build the future of women’s health care we all deserve. We look forward to partnering with the city and leaders in medicine and research to accelerate innovation and outcomes.” Read more here.
Evvy is the latest to join ASV’s growing portfolio of brands pioneering women’s health and sexual health solutions alongside Hey Jane, leading telehealth abortion provider, Contraline, the maker of male birth control and Dame Products, a leading female-focused sexual wellness brand. See the full portfolio here.
